|
 "Pfizer is among a number of companies that have received subpoenas
regarding this matter," the New York-based company said in an
emailed statement on Friday.
Drugmakers including Valeant Pharmaceuticals International Inc and
Regeneron Pharmaceuticals Inc have disclosed involvement in similar
government investigations.
In a regulatory filing on Thursday, Pfizer said the December 2015
and July 2016 subpoenas were related to groups that help cover
patient co-payments for prescription drugs.
Medicare is the U.S. government healthcare plan for seniors.
As aggressive price increases for certain prescription medications
have drawn the ire of politicians and the healthcare industry,
concern has grown that donations made by pharmaceutical companies to
patient assistance groups may be contributing to the price
inflation.
[to top of second column] |
"We support initiatives, including co-pay foundations, to help
patients most in need gain access to medicines," Pfizer said. "We
strive to follow government guidelines associated with any
contributions we make."
Pfizer said it has been providing information to the government in
response to the subpoenas.
(Reporting by Deena Beasley; Editing by Cynthia Osterman and Leslie
Adler)
[© 2017 Thomson Reuters. All rights
reserved.] Copyright 2017 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed. |
